GlassScriptPhysician profile
Nicholas Manguso
NPI 1093199457
$9,780.43
in general payments reported to CMS, 2019-2025
7 companies · $6,357 in 2025
The $6,357 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $22.92 · 2022: $122 · 2023: $30.95 · 2024: $2,248 · 2025: $6,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,600 · Travel and Lodging: $2,576 · Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,600.00 |
| Travel and Lodging | $2,575.54 |
| Food and Beverage | $460.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $8,445.53 | 2024-2025 | |
| Intuitive Surgical, INC. | $1,025.67 | 2019-2025 | |
| Springworks Therapeutics, INC. | $108.75 | 2024 | Ogsiveo |
| Medtronic, INC. | $104.95 | 2022 | |
| Tela Bio, INC. | $47.59 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sobi, INC | $30.95 | 2023 | |
| Smith+Nephew, INC. | $16.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Manguso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.